CA2373852A1 - Oligosaccharide aldonic acids and their topical use - Google Patents

Oligosaccharide aldonic acids and their topical use Download PDF

Info

Publication number
CA2373852A1
CA2373852A1 CA002373852A CA2373852A CA2373852A1 CA 2373852 A1 CA2373852 A1 CA 2373852A1 CA 002373852 A CA002373852 A CA 002373852A CA 2373852 A CA2373852 A CA 2373852A CA 2373852 A1 CA2373852 A1 CA 2373852A1
Authority
CA
Canada
Prior art keywords
well
aldonic acids
prevention
treatment
oligosaccharide aldonic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002373852A
Other languages
French (fr)
Other versions
CA2373852C (en
Inventor
Ruey J. Yu
Eugene J. Van Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2373852A1 publication Critical patent/CA2373852A1/en
Application granted granted Critical
Publication of CA2373852C publication Critical patent/CA2373852C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212—Face masks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners

Abstract

Compositions comprising oligosaccharide aldonic acids are useful for general care, as well as for treatment and prevention, of various cosmetic conditions and dermatological disorders, including those associated with intrinsic and/or extrinsic aging, as well as with changes or damage caused by extrinsic factors; general care, as well as treatment and prevention of diseases and conditions, of the oral, and vaginal mucosa; for general oral care, as well as treatment and prevention of oral and gum diseases; and for wound healing of the skin. Compositions comprising oligosaccharide aldonic acids may further comprise a cosmetic, pharmaceutical or other topical agent to enhance or create synergetic effects.
CA002373852A 1999-06-30 2000-06-28 Oligosaccharide aldonic acids and their topical use Expired - Lifetime CA2373852C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14126499P 1999-06-30 1999-06-30
US60/141,264 1999-06-30
US09/487,228 2000-01-19
US09/487,228 US6335023B1 (en) 1999-06-30 2000-01-19 Oligosaccharide aldonic acids and their topical use
PCT/US2000/016301 WO2001001932A2 (en) 1999-06-30 2000-06-28 Oligosaccharide aldonic acids and their topical use

Publications (2)

Publication Number Publication Date
CA2373852A1 true CA2373852A1 (en) 2001-01-11
CA2373852C CA2373852C (en) 2009-06-23

Family

ID=26838940

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002373852A Expired - Lifetime CA2373852C (en) 1999-06-30 2000-06-28 Oligosaccharide aldonic acids and their topical use

Country Status (16)

Country Link
US (2) US6335023B1 (en)
EP (1) EP1227820B1 (en)
JP (3) JP4326737B2 (en)
CN (1) CN1635864B (en)
AT (1) ATE323498T1 (en)
AU (1) AU775620B2 (en)
BR (1) BRPI0011640B8 (en)
CA (1) CA2373852C (en)
CY (1) CY1105407T1 (en)
DE (1) DE60027455T2 (en)
DK (1) DK1227820T3 (en)
ES (1) ES2262529T3 (en)
HK (1) HK1048764B (en)
MX (1) MX249762B (en)
PT (1) PT1227820E (en)
WO (1) WO2001001932A2 (en)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19646392A1 (en) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Preparation for use in the oral cavity with a layer containing pressure-sensitive adhesive, pharmaceuticals or cosmetics for dosed delivery
FR2775976B1 (en) * 1998-03-10 2000-06-02 Fabre Pierre Dermo Cosmetique PHARMACEUTICAL OR COSMETIC COMPOSITION CONTAINING AN ACTIVE PRECURSOR HYDROLYSABLE BY GLUCOCEREBROSIDASE
MXPA01007806A (en) * 1999-02-03 2003-06-04 Biogal Gyogyszergyar Process for the preparation of pseudomonic acid a antibiotic by microbiological method.
US6242491B1 (en) 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
US6335023B1 (en) * 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use
US7452545B2 (en) * 2001-11-13 2008-11-18 Yu Ruey J Oligosaccharide aldonic acids and their topical use
DE10114561A1 (en) † 2001-03-24 2002-09-26 Wella Ag Creatine, creatinine and/or their salts or derivatives are used in agents for repairing hair or increasing its gloss, volume or combability
WO2002096374A2 (en) * 2001-05-31 2002-12-05 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
EP1409703A4 (en) * 2001-06-21 2004-08-18 Biogal Gyogyszergyar Metabolic controlled fermentation process for pseudomonic acid production
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
FR2830449B1 (en) * 2001-10-05 2004-04-23 Fabre Pierre Dermo Cosmetique USE OF TAZAROTENE FOR THE PREPARATION OF A NAIL VARNISH FOR THE TREATMENT AND / OR PREVENTION OF PSORIASIS AND A NAIL VARNISH CONTAINING IT
US6824786B2 (en) * 2001-11-27 2004-11-30 Ruey J. Yu Compositions comprising phenyl-glycine derivatives
EP1455769A4 (en) 2001-12-28 2004-09-22 Biogal Gyogyszergyar Processes for preparing crystalline and amorphous mupirocin calcium
US6869598B2 (en) * 2002-03-22 2005-03-22 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Stabilization of sunscreens in cosmetic compositions
DE10214507A1 (en) * 2002-04-02 2003-10-16 Beiersdorf Ag Use of topical composition comprising acarbose or its derivatives to prevent or treat degenerative skin conditions, especially skin irritation, skin inflammation, atopic eczema and neurodermatitis
AU2003220691A1 (en) * 2002-04-10 2003-10-27 Van Scott, Eugene J. Urea compositions
US7622117B2 (en) * 2002-04-17 2009-11-24 Dynamis Therapeutics, Inc. 3-deoxyglucosone and skin
US6573301B1 (en) * 2002-04-23 2003-06-03 Bradley Pharmaceuticals, Inc. Carbamide peroxide compositions for the treatment of dermatological disorders and methods for their use
ATE516263T1 (en) * 2002-05-16 2011-07-15 Sunovion Pharmaceuticals Inc AMINES INHIBITING A MAMMAL ANANDAMIDE TRANSPORTER; AND METHODS OF USE THEREOF
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
US7780992B2 (en) * 2002-12-08 2010-08-24 Tareq Abduljalil Albahri Antiviral medicament
US20040151716A1 (en) * 2003-02-03 2004-08-05 Hamer Richard A. Material and method for treating microbial mediated dermatological conditions
US20040214215A1 (en) * 2003-03-07 2004-10-28 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
MXPA05009694A (en) * 2003-03-13 2005-10-20 3M Innovative Properties Co Methods of improving skin quality.
US20040220259A1 (en) * 2003-04-04 2004-11-04 Yu Ruey J. Topical treatment of dermatological disorders associated with reactive or dilated blood vessels
US7521459B2 (en) * 2003-07-28 2009-04-21 Metabeauty Inc. Method for treating damaged skin
US20060229258A1 (en) * 2003-07-30 2006-10-12 Daniela Serikaku Steroidal compositions containing hydroxycarboxylic acids and methods of using the same
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
CN101829319A (en) * 2003-12-08 2010-09-15 Cpex药品公司 The Pharmaceutical composition and the method that are used for insulinize
US7812049B2 (en) * 2004-01-22 2010-10-12 Vicept Therapeutics, Inc. Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists
WO2005084627A1 (en) * 2004-03-01 2005-09-15 University Of Iowa Research Foundation Alcohol-free chlorhexidine compositions
US20050196418A1 (en) * 2004-03-04 2005-09-08 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
JP2008500405A (en) * 2004-06-01 2008-01-10 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ Method for preparing an amorphous form of a drug
US7704522B2 (en) * 2004-09-08 2010-04-27 Clyde Morgan Topical medicament
EA014878B1 (en) * 2004-10-20 2011-02-28 Эндорешерш, Инк. Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cgmp phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
US20060110439A1 (en) * 2004-10-22 2006-05-25 Dynamis Therapeutics, Inc. Dermal delivery of n-methyl-glucamine and n-methyl-glucamine compounds
US20060193922A1 (en) * 2005-02-25 2006-08-31 Natalia Neikrug Compositions and methods for the treatment of acne
US7964582B2 (en) * 2005-03-21 2011-06-21 J&J Consumer Companies, Inc. Methods of treating skin and mucosal tissue atrophy using compositions including tensioning polymers
US8277780B2 (en) * 2005-05-27 2012-10-02 Taro Pharmaceutical North America, Inc. Stable liquid desoximethasone compositions with reduced oxidized impurity
US20070071705A1 (en) * 2005-09-29 2007-03-29 De Oliveira Monica A M Topical anti-microbial compositions
US8168206B1 (en) 2005-10-06 2012-05-01 Allergan, Inc. Animal protein-free pharmaceutical compositions
US7709014B2 (en) * 2005-10-17 2010-05-04 Yu Ruey J Hydroxy-oligocarboxylic esters: effects on nerve and use for cutaneous and mucocutaneous organs or sites
AU2007223560A1 (en) * 2006-03-01 2007-09-13 Tristrata, Inc. Composition and method for topical treatment of tar-responsive dermatological disorders
US7282224B1 (en) 2006-06-09 2007-10-16 Guthy-Renker Corporation Pain relief composition
US20080014252A1 (en) * 2006-07-14 2008-01-17 Delprete Keith Topical compositions with long lasting effect
US20080085331A1 (en) * 2006-10-06 2008-04-10 Gluskin Anna E Composition and method for raising blood glucose level
US20080107747A1 (en) * 2006-10-23 2008-05-08 Roederer Joy E Pain relief composition
WO2009002913A1 (en) * 2007-06-22 2008-12-31 Avicena Group, Inc. Use of creatine compounds to treat dermatitis
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
JP2011502510A (en) * 2007-11-08 2011-01-27 インタールーキン ジェネティクス， インコーポレイテッド Diagnosis of skin diseases related to aging
WO2009065116A1 (en) 2007-11-16 2009-05-22 Aspect Pharmaceuticals Llc Compositions and methods for treating purpura
US8866408B2 (en) * 2008-04-14 2014-10-21 Digital Lumens Incorporated Methods, apparatus, and systems for automatic power adjustment based on energy demand information
US8805550B2 (en) * 2008-04-14 2014-08-12 Digital Lumens Incorporated Power management unit with power source arbitration
US8754589B2 (en) * 2008-04-14 2014-06-17 Digtial Lumens Incorporated Power management unit with temperature protection
US8823277B2 (en) * 2008-04-14 2014-09-02 Digital Lumens Incorporated Methods, systems, and apparatus for mapping a network of lighting fixtures with light module identification
US10539311B2 (en) * 2008-04-14 2020-01-21 Digital Lumens Incorporated Sensor-based lighting methods, apparatus, and systems
WO2009129525A2 (en) * 2008-04-18 2009-10-22 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Antifungal and anti-cariogenic cellobio-oligosaccharides produced by dextransucrase
CN102088956A (en) * 2008-05-09 2011-06-08 托马有限公司 Proguanil to treat skin/mucosal diseases
US20110098246A1 (en) * 2008-06-06 2011-04-28 N.V. Nutricia Method for preventing corticosteroid usage
US20110092493A1 (en) * 2008-09-24 2011-04-21 Clark Levi Dose-controlled transdermal promethazine compositions and methods of use
RU2535003C2 (en) * 2008-12-10 2014-12-10 Аллерган, Инк. Pharmaceutical compositions of clostridia toxin
JP2012515170A (en) 2009-01-13 2012-07-05 シンギュラリス，インク． Therapeutic regulation of vaginal epithelial boundary lubrication
US8954170B2 (en) * 2009-04-14 2015-02-10 Digital Lumens Incorporated Power management unit with multi-input arbitration
IT1397735B1 (en) * 2010-01-18 2013-01-24 Binda COSMETIC COMPOSITION WITH MOISTURIZING AND ANTIOXIDANT ACTIVITY.
US20120027876A1 (en) * 2010-07-27 2012-02-02 Sara Beth Ford Composition and Method for the Topical Treatment of Dermatitis
JP6057496B2 (en) * 2010-12-24 2017-01-11 サンエイ糖化株式会社 Tooth enamel remineralization accelerator
WO2012177433A1 (en) * 2011-06-21 2012-12-27 Evologie Llc Topical compositions for the treatment of dermatological disorders
JP6222894B2 (en) * 2012-03-30 2017-11-01 小林製薬株式会社 Epidermis thickener
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
US9089506B2 (en) 2013-02-27 2015-07-28 Precision Dermatology, Inc. Stable, non-irritating topical formulations of hydroquinone
KR102559195B1 (en) 2013-08-15 2023-07-24 마리 케이 인코포레이티드 Topical skin compositions for treating wrinkles
JP6305727B2 (en) * 2013-10-31 2018-04-04 ポーラ化成工業株式会社 Skin photoaging prevention composition
JP6580342B2 (en) * 2014-02-28 2019-09-25 マルホ株式会社 Tropoelastin expression promoter and elastin production promoter
US10548835B2 (en) 2014-04-30 2020-02-04 Kimberly-Clark Worldwide, Inc. Methods of reducing the signs of skin aging
WO2015167557A1 (en) 2014-04-30 2015-11-05 Kimberly-Clark Worldwide, Inc. Topical compositions for stimulating adipogenesis and lipogenesis to reduce the signs of skin aging
MX366268B (en) 2014-04-30 2019-07-04 Kimberly Clark Co Topical composition including a combination of extracts for reducing signs of skin aging.
MX366466B (en) 2014-04-30 2019-07-10 Kimberly Clark Co Methods of reducing signs of skin aging using a combination of extracts.
GB2541316A (en) 2014-04-30 2017-02-15 Kimberley-Clark Worldwide Inc Compositions and methods for reducing oxidative stress
AU2014392629B2 (en) 2014-04-30 2021-04-01 Kimberly-Clark Worldwide, Inc. Use of Undaria extract to reduce signs of skin aging
EP4349414A2 (en) 2014-12-23 2024-04-10 Dyve Biosciences, Inc. Methods and formulations for transdermal administration
JP2015221821A (en) * 2015-08-11 2015-12-10 サンエイ糖化株式会社 Recalcification promoters for tooth enamel
AU2016346203B2 (en) 2015-10-30 2021-05-27 Leo Pharma A/S Isotretinoin formulations and uses and methods thereof
CN105853275B (en) * 2016-04-26 2018-10-02 上海波林丝生物科技有限公司 A kind of formula of the natural plants component of generating hair
GB2562270B (en) * 2017-05-10 2020-07-01 Hyphens Pharma Pte Ltd Skin barrier composition
US10556133B2 (en) 2017-06-05 2020-02-11 Momentive Performance Materials Inc. Composition and method for strengthening hair fiber
US20190083386A1 (en) 2017-09-15 2019-03-21 Ampersand Biopharmaceuticals, Inc. Methods and formulations for transdermal administration of buffering agents
CN111867568A (en) 2018-01-18 2020-10-30 C·阿尔诺德 Chewing gum compositions comprising polyhexamethylene guanidine
KR102199678B1 (en) * 2018-08-23 2021-01-07 주식회사 엘지생활건강 A composition for promoting the differentiation of human adipose derived stem cell
CN111514161B (en) * 2020-05-28 2021-05-04 江苏雪豹日化有限公司 Anti-oral ulcer preparation and application thereof
CN111690072B (en) * 2020-06-05 2021-05-28 江南大学 Preparation and application of polyaldehyde anti-crease finishing agent for cotton fabric
KR102598193B1 (en) * 2021-06-14 2023-11-06 대상 주식회사 Manufacturing method of matobionic acid using enzymatic oxidation
AU2021461617A1 (en) * 2021-08-23 2024-02-08 The Procter & Gamble Company Oral care compositions for gum health
CN117835961A (en) * 2021-08-23 2024-04-05 宝洁公司 Oral care composition for gingival health

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1772975A (en) 1925-06-20 1930-08-12 Firm C H Boehringer Sohn Chem Process for the production of antiseptic agents
US2118566A (en) 1935-08-29 1938-05-24 Miles Gilbert De Wayne Buffered cosmetic
US3227616A (en) 1961-07-03 1966-01-04 Warner Lambert Pharmaceutical Emulsions of cactus plant extract
US3689668A (en) 1967-10-18 1972-09-05 Emile Leon Piette Method of alleviating wrinkles on skin
SE325667B (en) 1968-03-06 1970-07-06 Medisan Ab
GB1316971A (en) 1969-05-20 1973-05-16 Hayashibara Co Process for production of aldobionic acids and their salts
FR2072692A5 (en) 1969-12-04 1971-09-24 Hayashibara Co
GB1388836A (en) 1971-06-01 1975-03-26 Medisan Ab Cosmetic compositions
US3879537A (en) 1973-09-04 1975-04-22 Scott Eugene J Van Treatment of ichthyosiform dermatoses
US3991184A (en) 1973-10-05 1976-11-09 Martin Kludas Agent for the care of skin
US4294852A (en) 1973-11-01 1981-10-13 Johnson & Johnson Skin treating compositions
US3984566A (en) 1974-02-25 1976-10-05 Scott Eugene J Van Method of alleviating the symptoms of dandruff
US3988470A (en) 1974-02-25 1976-10-26 Scott Eugene J Van Treatment of palmar and plant disturbed keratosis
ZA752066B (en) 1974-05-02 1976-03-31 Draco Ab Dermatologically active preparation
US4197316A (en) 1975-07-23 1980-04-08 Scott Eugene J Van Treatment of dry skin
US4363815A (en) 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
US4380549A (en) 1975-07-23 1983-04-19 Scott Eugene J Van Topical treatment of dry skin
US4021572A (en) 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
US4053630A (en) 1976-07-07 1977-10-11 Yu Ruey J Treatment of body odor and disturbed keratinization
BR7904612A (en) 1978-07-24 1980-04-08 Unilever Nv COMPOSITION COSMETICALLY ACCEPTABLE FOR TOPICAL APPLICATION, PROCESS TO PREPARE A COMPOSITION, APPLICATOR AND PROCESS TO PROVIDE SKIN ADVANTAGE
US4234599A (en) 1978-10-04 1980-11-18 Scott Eugene J Van Treatment of skin keratoses with α-hydroxy acids and related compounds
US4246261A (en) 1979-08-09 1981-01-20 Scott Eugene J Van Additives enhancing topical corticosteroid action
US4287214A (en) 1979-09-24 1981-09-01 Scott Eugene J Van Dithranol compositions stabilized with alpha hydroxyacids
AU548341B2 (en) 1982-02-02 1985-12-05 Unilever Plc Acne treatment composition
US4518789A (en) 1982-06-30 1985-05-21 Yu Ruey J Phenyl alpha-acyloxyacetamide derivatives and their therapeutic use
DE3239296A1 (en) * 1982-10-23 1984-06-14 Henkel Kgaa HAIR COSMETIC AGENTS
US4608370A (en) 1985-03-04 1986-08-26 Aronsohn Richard B Skin formulation
DE3540175C2 (en) 1985-11-13 1997-03-27 Merck Patent Gmbh Dithranol-containing pharmaceutical preparation
US4929722A (en) 1986-06-06 1990-05-29 Union Carbide Chemicals And Plastics Company Inc. Acid decrystallization of aminopolysaccharides and derivatives thereof
US5547988B1 (en) 1986-12-23 1997-07-15 Tristrata Inc Alleviating signs of dermatological aging with glycolic acid lactic acid or citric acid
US5091171B2 (en) 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
AU618517B2 (en) 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
US5686489A (en) 1986-12-23 1997-11-11 Tristrata Technology, Inc. Alpha hydroxyacid esters for skin aging
US4983382A (en) 1987-01-27 1991-01-08 Avon Products, Inc. Cosmetic preparation incorporating stabilized ascorbic acid
US5021451A (en) 1988-11-14 1991-06-04 Hoffman-La Roche Inc. Method for inhibiting hyperproliferative diseases
US5153230A (en) 1989-10-06 1992-10-06 Perfective Cosmetics, Inc. Topical skin cream composition
GB9003201D0 (en) 1990-02-13 1990-04-11 Unilever Plc Cosmetic composition
US5093109A (en) 1990-04-04 1992-03-03 Chanel, Inc. Cosmetic composition
US5290766A (en) 1991-02-18 1994-03-01 The National Heart Foundation Of New Zealand Cardioplegic compositions
ATE177629T1 (en) * 1991-04-10 1999-04-15 Yu Ruey J USE OF COMPOSITIONS CONTAINING 2-HYDROXYCARBONIC ACID OR DERIVATIVES THEREOF FOR RELIEVING OCEAN NAIL CHANGES
FR2681863B1 (en) 1991-09-27 1995-02-03 Rhone Dpc Europ SOLUTION OF SPARFLOXACIN, ITS PREPARATION AND SALT CONSTITUTING IT.
JP3082058B2 (en) * 1992-05-22 2000-08-28 株式会社ホーネンコーポレーション 6-O-α-D-galactopyranosyl-L-ascorbic acid or salt thereof, process for producing the same, and use thereof
JPH06263790A (en) * 1993-03-12 1994-09-20 Unitika Ltd 2-o-beta-d-galactopyranosyl-l-ascorbic acid or its salt, its production and use thereof
US5714163A (en) 1994-06-27 1998-02-03 Nexstar Pharmaceuticals, Inc. Vinca alkaloid vesicles with enhanced efficacy and tumor targeting properties
JPH08291192A (en) * 1995-04-25 1996-11-05 Nippon Shokuhin Kako Co Ltd Lactonized oligosaccharide, its production and alpha amylase inhibitor
US5877212A (en) 1997-04-16 1999-03-02 Yu; Ruey J. Molecular complex and control-release of alpha hydroxyacids
US6159480A (en) * 1997-12-15 2000-12-12 Neostrata Company, Inc. Cosmetic makeup composition
US6335023B1 (en) * 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use

Also Published As

Publication number Publication date
HK1048764B (en) 2006-09-15
CY1105407T1 (en) 2010-04-28
EP1227820B1 (en) 2006-04-19
JP4804018B2 (en) 2011-10-26
WO2001001932A2 (en) 2001-01-11
US20020028227A1 (en) 2002-03-07
HK1048764A1 (en) 2003-04-17
BR0011640A (en) 2002-05-14
JP2005232180A (en) 2005-09-02
WO2001001932A3 (en) 2001-05-17
BRPI0011640B8 (en) 2021-05-25
ES2262529T3 (en) 2006-12-01
JP2011140499A (en) 2011-07-21
JP2003503436A (en) 2003-01-28
US6335023B1 (en) 2002-01-01
ATE323498T1 (en) 2006-05-15
CN1635864B (en) 2010-06-16
EP1227820A2 (en) 2002-08-07
AU775620B2 (en) 2004-08-05
DE60027455T2 (en) 2006-12-14
US6740327B2 (en) 2004-05-25
PT1227820E (en) 2006-08-31
DE60027455D1 (en) 2006-05-24
MX249762B (en) 2007-10-01
AU6335300A (en) 2001-01-22
DK1227820T3 (en) 2006-08-21
BR0011640B1 (en) 2014-07-29
CA2373852C (en) 2009-06-23
JP4326737B2 (en) 2009-09-09
MXPA01013042A (en) 2003-08-20
CN1635864A (en) 2005-07-06

Similar Documents

Publication Publication Date Title
CA2373852A1 (en) Oligosaccharide aldonic acids and their topical use
CA2389167A1 (en) Pharmaceutical formulations of resveratrol and methods of use thereof
MY144292A (en) Method of reducing oral tissue inflammation using magnolia extract
PT1326613E (en) USE OF IMIDAZO [1,2-A] PYRIDIN-, IMIDAZO [1,2-A] PYRIMIDIN- AND IMIDAZO [1,2-A] PYRAZIN-3-IL-AMINE DERIVATIVES FOR THE MANUFACTURE OF MEDICINES FOR INHIBITION OF WE
EP2039355A3 (en) Topical use of valproic acid for the prevention or treatment of skin disorders
CA2392879A1 (en) A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
BRPI9908182C1 (en) matrix protein compositions for wound healing
WO2009106963A2 (en) Dental composition for preventing and treating stomatitis and mouth ulcers
EP1444984B1 (en) Topical pharmaceutical compositions containing natural active constituents suitable for the prevention and treatment of mucosal inflammation processes
JP5981419B2 (en) Tamarind seed polysaccharide for use in the treatment of inflammatory diseases
WO2003022218A3 (en) Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof
US20020039559A1 (en) Oral care composition
DE3688787D1 (en) PRODUCTION OF A MEDICINE AGAINST ARTHRITIS AND RHEUMATISM.
CN1357310A (en) Soluble pearl powder compound
JP2002338457A (en) Prophylactic/therapeutic agent for periodontosis
CN107854375A (en) A kind of anti-inflammatory whitening toothpaste
HUP0102702A3 (en) Pharmaceutical composition on the basis of erythromycin fatty acid salts for the topical treatment of skin diseases
CN108030727A (en) A kind of anti-inflammatory hemostatic toothpaste
CN107982137A (en) A kind of degerming dental plaque cream containing chlorophyll
CN107854376A (en) A kind of toothpaste containing chlorophyll
SHARMA REVIEWING DANTA GATA (DENTAL) VISHA CHIKITSA IN PRESENT DAY ORO-DENTAL DISEASES-AN AYURVEDA CONCEPT
CN107982142A (en) A kind of antibacterial hemostasis toothpaste
JP2003183170A (en) Gargle preparation
BR0206336A (en) Process of Preparation of Slow Release Antimicrobial, Anesthetic, Antifungal and Anti-Inflammatory Pharmaceutical Compositions and Derived Products
CA2379435A1 (en) Topical azathioprine for the treatment of oral autoimmune diseases

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20200629